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Background We examined HIV prevalence trends over 4.5 years among women
receiving antenatal care in Kinshasa, Democratic Republic of Congo,
by geographic location, clinic management and urbanicity.
Methods Quarterly proportions and 95% confidence intervals (CIs) of preg-
nant women with HIV positive results were determined using
aggregate service provision and uptake data from 22 maternity
units that provided vertical HIV prevention services from October
2004 to March 2009. Assuming linearity, proportions were assessed
for trend via the Cochran–Armitage test. Multivariable binomial
regression was used to describe detailed prevalence trends.
Results HIV testing was offered to 220 006 pregnant women; 210 348 (95.6%)
agreed to be tested and 191 216 (90.9%) received their results. A total
of 3999 women were found to be HIV positive, a prevalence of 1.90%
(95% CI: 1.84–1.96%). The median quarterly proportion of women
testing positive for HIV was 1.94% (range: 1.44–2.44%). Prevalence
was heterogeneous in terms of maternity management, urbanicity
and geographic location. Modeling suggested that the overall preva-
lence dropped from 2.04% (95% CI: 1.92–2.16%) to 1.77% (95% CI:
1.66–1.88%) over 4.5 years, a relative decrease of 13.2% (95% CI:
3.53–22.9%). Trend testing corroborated this decline (P < 0.01).
Conclusions The decreasing HIV prevalence among Kinshasa antenatal care
seekers is robust and encouraging. The relatively low prevalence
and the weak existing healthcare system require prevention of
mother-to-child transmission interventions that strengthen mater-
nal and child healthcare service delivery. Complacency would
be unwarranted: assuming a uniform national crude birth rate of
50/1000 and 1.8% antenatal HIV prevalence, approximately 7000
pregnant HIV infected women in Kinshasa, and 60 000 nationwide,
are in need of care and prevention services yearly.
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delivery, Democratic Republic of Congo, HIV seroprevalance, HIV
surveillance, time trends
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There is limited recent information on the prevalence
of HIV, especially over time, in the Democratic
Republic of Congo (DRC). Decades of deteriorating
social, political, and economic conditions and civil
wars resulting in the deaths of 4 million1
Congolese crippled healthcare systems and precluded
the study of HIV prevalence trends. Although relative
peace has returned to large parts of this nation of
approximately 69 million citizens,2 recovery and de-
velopment of vital infrastructures has been slow.
Public health continues to suffer—a survey published
in June 2009 notes that the mortality rate in the DRC
remains 55% higher than the reported baseline for
sub-Saharan Africa, primarily because of post-conflict
malnutrition and infectious disease.3
Serosurveys of approximately 11 000 pregnant
women who delivered at the central hospital in the
capital, Kinshasa, yielded an HIV prevalence of 5.8%
in 1986 and 6.1% in 1989.4 A prevalence of HIV of
3.1% was found in a 1997 serosurvey of 516 pregnant
women receiving antenatal care (ANC) in Kinshasa.5
In 2003, the prevalence was 4.1% among 1092 preg-
nant women tested for HIV at a single Kinshasa ANC
clinic.6 This clinic was also featured in another study,
which reported that the prevalence among 2082
women presenting to two Kinshasa maternity units
in 2004 was 1.9%.7 The 2008 UNAIDS/WHO
Epidemiological Fact Sheet on HIV and AIDS for the
DRC states that prevalence ranged from 2.7 to 4.1%
between 2002 and 2004 at one Kinshasa ANC site and
between 3.2 and 4.3% at three other sites.8 In 2006, a
population-based serosurvey in Kinshasa found that
3.6% of 1338 women aged 15–49 years were HIV
infected.9
Although these sources provide some information
on HIV prevalence among pregnant women, they
also highlight several gaps. For example, no studies
specifically address prevalence over time, meaning
that it is unknown whether the recently described
decreasing HIV prevalence among women seeking
ANC in countries such as Zambia,10 Cameroon11 and
Botswana12 is also occurring in the DRC. Research in
sub-Saharan Africa has demonstrated that HIV preva-
lence within an area can differ by urbanicity13–15 and
geographic location,16–18 factors that may serve to
inform future prevention efforts. Whether HIV preva-
lence is heterogeneous within the city of Kinshasa
remains to be elucidated.
Services to prevent mother-to-child HIV transmis-
sion (PMTCT), including provision of prophylactic
single-dose nevirapine (sdNVP), were first initiated
in 2003 in two Kinshasa maternity units. Additional
public- and private-sector facilities joined our program
in five subsequent waves, and by 2009 activities had
been implemented in a total of 37 of the city’s largest
maternity units. Given that HIV counselling and test-
ing is an integral component of PMTCT and that tens
of thousands of women annually seek ANC at
maternity units diverse in their management, urbani-
city and location, these clinics provide an ideal setting
to achieve our study aim: to provide novel insight on
HIV prevalence among pregnant women in Kinshasa,
both overall and within potentially important sub-
groups. We investigated trends between 2004 and
2009.
Methods
The 22 maternity units in Kinshasa that provided
comprehensive vertical HIV prevention services be-
tween October 2004 and March 2009 provided data
for the study. This period was selected because it
maximized the period of continuous participation for
a constant sample of facilities; data were available for
1155 of 1188 maternity months (97.2%). As depicted
in Figure 1, the maternity units varied in terms of
management (nine government, nine run by
Catholic organisations, four run by Protestant organ-
isations), urbanicity (17 urban, five peri-urban) and
Kinshasa geographic sector (five Funa, eight Lukunga,
five Mont Amba, four Tshangu). Urbanicity is defined
by DRC governmental criteria; non-rural areas that
are less developed and densely populated than that
of urban areas are peri-urban.
On a monthly basis, individual clinics entered
75 distinct monitoring indicators into a central data-
base. These indicators included counts of pregnant
women who were offered HIV testing, tested for
HIV, tested HIV positive, and took sdNVP during
labour. After collapsing data into 18 quarterly periods
to reduce individual estimate variability, secondary
indicators such as HIV prevalence and uptake of
HIV testing were calculated.
Prevalence trends, assumed to be linear on the basis
of examination of the data and studies in other ANC
settings in sub-Saharan Africa, were assessed with the
Cochran–Armitage test (a left-sided P-value <0.05
was evidence against the null hypothesis of no
decreasing trend). To further describe trends, we
modelled the prevalence difference using multivari-
able binomial regression with an identity link. All
models included month, which was coded discretely
from 0 to 53. Other factors hypothesized to be asso-
ciated with HIV prevalence, as well as interaction
terms between month and these factors, were
additionally included if the P-value for a likelihood
ratio test comparing models with and without tested
parameters was <0.10. Coded as categorical disjoint
indicator variables, the maternity-level factors con-
sidered were management, urbanicity and geographic
sector.
Wilson’s method19 was used to calculate point esti-
mates and 95% confidence intervals (CIs) for propor-
tions, which were compared by the chi-square test.
Analyses were completed using Microsoft Excel 2003
(Microsoft Corporation, Redmond, WA) and SAS 9.1.3
(SAS Institute, Cary, NC). The research was approved
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by the University of North Carolina at Chapel Hill
Institutional Review Board and the Ethics
Committee of the Kinshasa School of Public Health.
Results
During the 4.5-year study period, both testing uptake
and receipt of test results were consistently high
(Table 1). Of the 220 006 pregnant women offered
HIV testing, 95.6% agreed to be tested. Between
9647 and 14 984 women per quarter (median:
11 388) accepted HIV testing; the median quarterly
proportion of women who accepted HIV testing was
95.8% (range: 90.6–98.9%). Of women tested, 191 216
(90.9%) were informed of their test results. Between
8856 and 13 514 women per quarter (median: 10 453)
received their results; the median quarterly proportion
of women who received their results was 90.5%
(range: 81.1–98.8%).
The overall prevalence of HIV was 1.90% (95% CI:
1.84–1.96%), with 3999 of 210 348 women testing
seropositive. Between 169 and 274 women per quarter
(median: 224) tested HIV positive. The median quar-
terly proportion of women testing positive for HIV
was 1.94%, and fluctuated between 1.44% in the
third quarter of 2008 and 2.44% in the second quarter
of 2007.
The prevalence of HIV was heterogeneous in terms
of maternity management, urbanicity and geographic
sector (all P < 0.01). In government-run maternity
units, 2.49% (95% CI: 2.35–2.63%) of women tested
for HIV were seropositive. This prevalence was higher
(P < 0.01) than that in facilities run by Protestant or-
ganisations (1.90%; 95% CI: 1.75–2.05%), which was
higher (P¼ 0.01) than that in the Catholic network
(1.69%; 95% CI: 1.62–1.76%). The prevalence in
peri-urban maternity units was 1.08% (95% CI:
0.98–1.18%), substantially lower (P < 0.01) than that
in urban maternity units 2.13% (95% CI: 2.06–2.20%).
Although the HIV prevalence in Tshangu (1.96%; 95%
CI: 1.86–2.06%) and Lukunga (1.85%; 95% CI: 1.76–
1.93%) clinics were similar (P¼ 0.10), the prevalence
of HIV in Mont Amba clinics (1.56%; 95% CI: 1.40–
1.72%) was lower than that in Lukunga clinics
(P < 0.01), and the prevalence in Funa clinics
(2.33%; 95% CI: 2.13–2.53%) was higher than that
in Tshangu clinics (P < 0.01).
Overall, the prevalence of HIV decreased over time
(Cochran–Armitage P < 0.01; Figure 2). There was
strong evidence of decreasing prevalence in peri-urban
(P < 0.01) and government-run (P < 0.01) facilities;
the trend was downward but less dramatic in urban
facilities (P¼ 0.08) and those managed by Protestant
(P¼ 0.07) and Catholic (P¼ 0.06) organisations.
Prevalence decreased in Funa, Mont Amba and
Tshangu clinics (all P < 0.05) but was constant in
Lukunga clinics (P¼ 0.15). Receipt of test results
increased over time (P < 0.01), as described in our
prior study,20 as did uptake of HIV testing
(P < 0.01). All conclusions about trend were identical
whether data were considered monthly or collapsed
into quarters.
In a binomial regression model with month as the
single independent variable, the HIV prevalence
dropped from 2.04% (95% CI: 1.92–2.16%) in
October 2004 to 1.77% (95% CI: 1.66–1.88%) in
March 2009 (Table 2). This absolute decrease of
0.27% (95% CI: 0.07–0.47%) was equivalent to a
13.2% (95% CI: 3.53–22.9%) relative decrease.
Figure 1 Locations and characteristics of 22 maternity units providing vertical HIV prevention services in Kinshasa, DRC,
between October 2004 and March 2009
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In addition to month, the multivariable model con-
structed to represent changes in prevalence with
respect to other maternity-level factors included inde-
pendent variables for management and urbanicity
along with interaction terms between month and
management as well as month and urbanicity.
This analysis, which was corroborated by Cochran–
Armitage trend testing, suggested that though the
prevalence of HIV held steady in urban maternity
units managed by Protestant and Catholic organisa-
tions, it fell in peri-urban and government-run facil-
ities. The model indicated that government-run urban
maternity units experienced the greatest absolute
decline in prevalence during the study period, 1.26%
(95% CI: 0.72–1.80%), whereas the greatest relative
decline, 51.9% (95% CI: 27.7–76.1%), occurred in
Catholic-managed peri-urban maternity units.
Consistent with the finding of prominently different
prevalences between urbanicity strata, the model con-
veyed that the October 2004 prevalence in peri-urban
clinics was 0.51% (95% CI: 0.26–0.77%) lower (in
absolute terms) than that in urban clinics, with this
gap widening by an additional 0.02% per month.
Discussion
Data from 22 maternity units offering PMTCT services
in Kinshasa, DRC, provide strong evidence that the
prevalence of HIV declined between October 2004
Figure 2 HIV prevalence at 22 Kinshasa maternity units, by quarter, 20042009
Table 1 HIV prevalence monitoring indicators for 22 maternity units providing vertical HIV prevention services in
Kinshasa, DRC, October 2004 to March 2009
4.5 years total Quarterly median High quarter Low quarter
Women counselled for HIV testing 220 006 11 879 15 690 10 072
Women tested for HIV 210 348 11 388 14 984 9637
Women informed of HIV test result 191 216 10 453 13 514 8856
Women tested positive for HIV 3999 224 274 169
HIV testing uptake (%) 95.6 95.8 98.9 90.7
HIV test result receipt (%) 90.9 90.5 98.8 81.1
HIV prevalence (%) 1.90 1.94 2.44 1.44
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and March 2009 among women receiving ANC at
these clinics. In addition to a decreasing proportion
of seropositive women over time noted via trend test-
ing, a linear model fit to the 18 quarterly data points
indicated a reduction in prevalence during the study
period. The precise drivers of this finding are up for
debate, particularly given that essential age-specific
prevalence estimates and trends are unknown.
Our results are remarkably in line with the findings
of the Demographic and Health Survey (DHS) con-
ducted in 2007.21 The HIV prevalence study con-
ducted on a subsample of the study population
provided an overall prevalence of 1.6% (95% CI: 1.2–
2.0%) in 4492 adult women countrywide. In
Kinshasa, the HIV prevalence among 709 women
was 2.3% (95% CI: 1.2–3.4%). The marked difference
between these results and the 4.1% prevalence of HIV
obtained by the national sentinel surveillance system
in 2006 from 11 719 pregnant women throughout the
country raised questions among Congolese health
authorities regarding the reliability of the DHS data.
Our data convey strong additional plausibility to the
results of the DHS.
Although the DHS results and our data reinforce
each other, the sustained decline of HIV prevalence
over time, in the country and in Kinshasa in particu-
lar, cannot be explained easily. It is plausible that
sexual behaviour change, proposed as an explanation
for reduced antenatal prevalence in other sub-
Saharan African locales,17,22,23 plays a contributing
role. Support for this theory, however, is limited—
despite widespread risk-reduction campaigns24 and
increased condom sales25 during the past decade,
contraceptive use and knowledge of HIV prevention
in the DRC remain extremely low.21,26,27 In addition
to prevention programs, high AIDS-related mortality
because of very low coverage of antiretroviral
treatment programs could explain the declining
prevalence.
As there is a scarcity of knowledge about the preva-
lence in HIV in the DRC, this study contributes
novel information about the Kinshasa epidemic’s evo-
lution in recent years. Furthermore, it demonstrates
that HIV prevalence is heterogeneous in this setting,
with variation by maternity management, urbanicity
and geographic location. One particularly striking
finding was that the HIV prevalence in peri-urban
maternity units was approximately half of that in
urban maternity units. This mirrors recent studies
from Uganda that report lower prevalence in
peri-urban ANC facilities relative to urban facil-
ities.13,14 We hypothesize that the underlying deter-
minants28 of this disparity include differentials in
population density29,30 (greater in urban Kinshasa
than in peri-urban Kinshasa31), proximity to urban
military and police camps (soldiers throughout
Africa are more likely to be infected than the general
population32) and socialization and economic oppor-
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behaviours and HIV risk. Assessed geographic areas
were similar in terms of prevalence trend, with
three of four sectors decreasing over time, but were
variable in terms of absolute prevalence. The same
contextual factors thought to explain the dissimilarity
by urbanicity, in addition to urbanicity itself, are
believed to account for this difference. In the higher
prevalence Funa and Tshangu sectors, sampled mater-
nity units tended to be closer to the city centre or
highly crowded communes,31 whereas sampled
maternity units in Lukunga and Mt. Amba were
more often peri-urban.
We previously described not only that vertical HIV
prevention programs at government-run facilities in
Kinshasa have performed more poorly than programs
at facilities managed by religious organisations in
terms of testing uptake, receipt of test results, and
successful provision of sdNVP to mother and infant,
but also that ANC and delivery costs tend to be higher
in government-run clinics.20 These findings may help
explain the noted prevalence differences by maternity
management. DRC-specific evidence on the mobility
and socio-economic status of HIV infected women
(relative to uninfected women) does not exist. We
can speculate that seropositive ANC seekers had on
average decreased logistical and financial capacity to
obtain care at lower-cost, higher-quality maternity
units managed by religious organisations. The fact
that government-managed maternity units tested a
lower percentage of women than other types of
maternity units strengthens the case that prevalence
was truly higher at those facilities. If, indeed, testing
is often refused because of denial and fear,35 it
is expected that untested women were more likely
to be infected than that of tested women. A greater
number of untested women might therefore bias
the observed prevalence downwards, although the
impact of non-tested subjects has been considered to
have a small effect on the population prevalence
estimate.36
Assuming that most women seek ANC in maternity
units close to their homes,14 meaning, for example,
that women presenting at peri-urban maternity
units live in peri-urban areas, the heterogeneities in
prevalence observed in this study offer unique insight
on specific HIV foci in Kinshasa. Although it is
acknowledged that sentinel surveillance of ANC cli-
ents can overestimate the overall proportion of resi-
dents who are HIV positive,37,38 there is a logical and
likely correlation between patterns among pregnant
women and the true prevalence in the overall popu-
lation, which makes sentinel surveillance of pregnant
women particularly appropriate to follow trends over
time.
Suppositions like higher urban prevalence, reason-
able but heretofore empirically undemonstrated, are
strongly supported if not confirmed. The findings of
the 2007 DHS also showed that HIV prevalence
among women was substantially higher in urban
than in rural areas: 2.4% (95% CI: 1.8–3.1%) versus
1.0% (95% CI: 0.7–1.5%).21 Since 33% of the total
Congolese population lives in urban areas, and
Kinshasa alone accounts for one-third, it makes
sense to develop PMTCT interventions in the capital
city.
At 2%, the prevalence of HIV among women
receiving ANC in Kinshasa is markedly lower than
in various other sub-Saharan African settings—in
Botswana, in 2006, almost 40% of tested pregnant
women were HIV infected.39 It may seem injudicious
to highlight mother-to-child HIV transmission as an
urgent local issue when antenatal prevalence is so
much higher elsewhere, but focusing on the disparity
underemphasizes the extent of the problem. Vertical
HIV transmission is an important public health prob-
lem in the DRC given the large population coupled
with a birth rate that is the highest in the world.40
PMTCT service delivery is low in the DRC. Although
37 of the larger maternity units in Kinshasa now offer
HIV testing and sdNVP, coverage is much worse out-
side of the capital. In 2007, only a third of health
zones nationwide had at least one PMTCT facility,
and although 485% of the Congolese population
does not live in Kinshasa, 70% of antenatal HIV
tests were completed outside the city.9 Assuming a
uniform national birth rate of 49.6/1000 and the
model-predicted March 2009 antenatal HIV preva-
lence of 1.77%, there are approximately 7000
HIV positive pregnant women in Kinshasa, and
60 000 in the country, annually in need of HIV pre-
vention and care services. These figures contrast with
our program that identifies approximately 1000
seropositive women per year, of whom fewer receive
effective prophylaxis due to inevitable attrition at
each step of the cascade.41 Given that the risk of ver-
tical transmission may reach 45% in the absence of
intervention,42 it can be calculated that at least 5% of
the world’s new paediatric HIV cases (an estimated
370 000 in 2007)43 occur in the DRC. Far fewer chil-
dren are infected in higher prevalence nations with
better PTMCT coverage.
Compared with other African nations, including
countries surrounding the DRC, the low HIV preva-
lence coupled with a considerable burden of health
problems resulting from poor healthcare services and
poverty may suggest that PMTCT is a relative luxury.
However, PMTCT is closely associated with many
aspects of maternal and child healthcare, from ANC
to safe delivery to postnatal care. In addition to pre-
venting paediatric HIV, PMTCT programs can be an
opportunity for strengthening existing services, e.g. by
training and supervising healthcare providers and
developing infrastructure to improve reproductive
health and maternal and child healthcare. We docu-
mented at the outset of our program in 2003 that
PMTCT should be delivered in settings like DRC
through a comprehensive approach that improves
existing service delivery.44
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Our study has several strengths. First, we utilized a
large, geographically diverse sample of maternity
units that collectively serve a considerable number
of ANC clients. This raises the likelihood that the
women considered were representative of all pregnant
women in Kinshasa, and thereby improves internal
generalizability. Our data were remarkably complete
as well as derived from a sample of clinics that was
constant over time, which reduces the possibility of
biased or invalid inferences about trend. In addition,
high uptake of testing contributed to the robustness
of results. If the seroprevalence among women not
tested for HIV was uniformly 5 or 0.5%, the preva-
lence would have been 2.04 or 1.84%, close to the
1.90% observed. In a scenario of a uniform 5% preva-
lence among untested women, extreme given its con-
stancy and magnitude, the overall relative decrease
during the study period would have been 17.4%, simi-
lar to the actual decrease of 13.2%. One study limita-
tion was a lack of individual-level data, which
prevented informative subgroup analyses and investi-
gations of associations between infection and personal
demographic factors.
In conclusion, the prevalence of HIV among women
receiving ANC at 22 clinics in Kinshasa decreased be-
tween October 2004 and March 2009, with clear dif-
ferences noted by maternity management, urbanicity
and geographic location. The relative decrease of 13%
was remarkably similar to the 13% relative decrease
observed among more than 243 000 pregnant women
tested during a recent 4.5-year period in Zambia.10
Although this finding of decreasing prevalence is
encouraging, further understanding and mitigation
of the epidemic in the DRC will require sustained
local and international commitment to strengthen
and scale-up HIV prevention and treatment programs.
Although this will be challenging in Kinshasa and
even more difficult in other parts of the country, con-
sideration of apparent trends alongside recent expan-
sions and successes in PMTCT and HIV care and
treatment service provision provide hope for contin-
ued progress.
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